FIELD: pharmacology.
SUBSTANCE: composition is designed to prevent and treat motion sdiseases, to treat the vestibular symptoms of Meniere's disease and vestibular syndromes after middle ear surgeries. The composition contains pyrroxane, trifazine and diferidine in a weight ratio of 10:1:2. The medicinal form can have various implementations, in particular the medicinal form can be designed with possibility of oral, buccal, transdermal and/or parenteral use.
EFFECT: increased efficiency of composition application.
4 cl, 8 ex, 5 tbl
Authors
Dates
2017-08-28—Published
2015-02-17—Filed